Mercer Global Advisors
ASTH icon

Mercer Global Advisors’s Astrana Health ASTH Stock Holding History

Mercer Global Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.4K Buy
+1,733
New +$62.4K ﹤0.01% 3995

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mercer Global Advisors's ASTH Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Astrana Health (ASTH) in Q2 2026: 1,733 shares worth $80.4K. The stake represents ﹤0.01% of the portfolio and ranks #3995 among its holdings.

195 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Mercer Global Advisors held 1,733 shares of Astrana Health worth $80.4K as of Q2 2026.
  • Astrana Health was a new Mercer Global Advisors position in Q2 2026.
  • Astrana Health made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3995 holding.
  • 195 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.